abacavir 300 MG Oral Tablet

1 INDICATIONS AND USAGE Abacavir tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. Abacavir tablets, a nucleoside analogue human immunodeficiency virus (HIV-1) reverse transcriptase inhibitor, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )

Mylan Pharmaceuticals Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] febrile neutropenia` `[4] pyrexia` `[5] nausea` `[6] toxicity to various agents` `[7] vomiting` `[8] diarrhoea` `[9] neutropenia` `[10] death`

4 years ago

OVAL ORANGE M 120

16 HOW SUPPLIED/STORAGE AND HANDLING Abacavir Tablets, USP are available containing

ABACAVIR SULFATE, USP equivalent to 300 mg of abacavir. The 300 mg tablets are peach, film-coated, capsule shaped, scored tablets debossed with M on one side of the score and 120 on the other side of the score on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-4105-91 carton of one bottle containing 60 tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in original container with attached prescribing information that contains the Medication Guide and a Warning Card.

More pills like OVAL M 120

Related Pills

diltiazem 120 mg

bryant ranch prepack

guaifenesin and dextromethorphan hydrobromide tablet extended release

ohm laboratories inc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site